Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® measles igg assay uses chemiluminescence immunoassay (clia) technology for the semi- quantitative determination of specific igg antibodies to measles virus in human serum samples. it is intended to be used as an aid in the determination of serological status to measles virus. the test has to be performed on the liaison® analyzer family.

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® mumps igg assay uses chemiluminescence immunoassay (clia) technology for the semi- quantitative determination of specific igg antibodies to mumps virus in human serum samples. it is intended to be used as an aid in the determination of serological status to mumps virus. the test has to be performed on the liaison® analyzer family.

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® vzv igg assay uses chemiluminescence immunoassay (clia) technology for the quantitative determination of specific igg antibodies to varicella-zoster virus (vzv) in human serum samples. the test has to be performed on the liaison® analyzer family

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® mycoplasma pneumoniae igg assay uses chemiluminescence immunoassay (clia) technology for the semi-quantitative determination of specific igg antibodies to mycoplasma pneumoniae in human serum samples. the test has to be performed on the liaison® analyzer family.

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® mycoplasma pneumoniae igm assay uses chemiluminescence immunoassay (clia) technology for the qualitative determination of specific igm antibodies to mycoplasma pneumoniae in human serum samples. the test has to be performed on the liaison® analyzer family.

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® direct renin assay uses chemiluminescence immunoassay (clia) technology for the in vitro quantitative determination of renin in human edta-plasma specimens. renin measurement is of help in the diagnosis and treatment of a number of hypertension types in humans. the test has to be performed on the liaison® analyzer family.

Singapura - Inggeris - HSA (Health Sciences Authority)

spd scientific pte ltd - immunology - the liaison® aldosterone assay uses chemiluminescent immunoassay (clia) technology and is intended for the quantitative determination of aldosterone in human serum, edta plasma and treated urine samples. aldosterone measurements are intended for use in the diagnosis and treatment of primary aldosteronism (a disorder caused by excessive secretion of aldosterone by the adrenal gland), hypertension caused by primary aldosteronism, selective hypoaldosteronism, edematous states and other conditions of electrolyte imbalance. the test has to be performed on the liaison® analyzer family*.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

physicians total care, inc. - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 1000 mg - canasa® 1000 mg suppositories are indicated for the treatment of active ulcerative proctitis. canasa® 1000 mg suppositories are contraindicated in patients who have demonstrated hypersensitivity to mesalamine (5-aminosalicylic acid) or to the suppository vehicle [saturated vegetable fatty acid esters (hard fat, nf)], or to salicylates (including aspirin).

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

mckesson rxpak inc - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 1000 mg - canasa is indicated in adults for the treatment of mildly to moderately active ulcerative proctitis. canasa is contraindicated in patients with known or suspected hypersensitivity to salicylates or aminosalicylates or to any ingredients in the suppository vehicle [see warnings and precautions (5.3), adverse reactions (6.2), and description (11)] . risk summary limited published data on mesalamine use in pregnant women are insufficient to inform a drug-associated risk. no evidence of teratogenicity was observed in rats or rabbits when treated during gestation with orally administered mesalamine at doses greater than the recommended human intra-rectal dose [see data] . the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. adverse outcomes in pregnancy occur regardless of the health of the mother or the use of medications. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnanci

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 1000 mg - canasa is indicated in adults for the treatment of mildly to moderately active ulcerative proctitis. canasa is contraindicated in patients with known or suspected hypersensitivity to salicylates or aminosalicylates or to any ingredients in the suppository vehicle [ s ee warnings and precautions ( 5.3 ), adverse reactions ( 6.2 ), and description ( 11 )] . risk summary limited published data on mesalamine use in pregnant women are insufficient to inform a drug-associated risk. no evidence of teratogenicity was observed in rats or rabbits when treated during gestation with orally administered mesalamine at doses greater than the recommended human intra-rectal dose ( see data ) . the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. adverse outcomes in pregnancy occur regardless of the health of the mother or the use of medications. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recogni